Cargando…
Advances in Epigenetic Cancer Therapeutics
Cancer has traditionally been hailed a genetic disease, dictated by successive genetic aberrations which alter gene expression. Yet, recent advances in molecular sequencing technologies, enabling the characterisation of cancer patient phenotypes on a large scale, have highlighted epigenetic changes...
Autores principales: | Hillyar, Christopher, Rallis, Kathrine S, Varghese, Jajini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772155/ https://www.ncbi.nlm.nih.gov/pubmed/33391954 http://dx.doi.org/10.7759/cureus.11725 |
Ejemplares similares
-
Recent advances in epigenetic anticancer therapeutics and future perspectives
por: Ren, Liwen, et al.
Publicado: (2023) -
Editorial: Epigenetic and Transcriptional Dysregulations in Cancer and Therapeutic Opportunities
por: Ansari, Rais A., et al.
Publicado: (2022) -
Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2018) -
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
por: Martinez, Victor G., et al.
Publicado: (2019) -
Corrigendum: Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2019)